Abstracts

Preclinical to Human Scaling of Pharmacokinetics for Long-Acting Injectable Antiretrovirals

Background: Long-acting injectables (LAIs) have attracted interest for prevention and treatment of infection (including HIV, HCV and tuberculosis), addressing issues with pill burden and adherence. Better methods for scaling preclinical pharmacokinetics (PK) for prediction of human exposure are needed to aid decision making, and accelerate early clinical development through better human dose prediction. Methods: Matching…

Implementation of an Online Drug-Drug Interaction Screener for STRIVE Ensitrelvir Trial for COVID

Background: Ensitrelvir (ESV) is an investigational oral protease inhibitor for SARS-CoV-2 infection currently being studied in a randomized placebo-controlled trial of patients hospitalized for COVID-19 within STRIVE (Strategies and Treatments for Respiratory Infections and Viral Treatments), a global network. ESV is associated with drug-drug interactions (DDI) due to its inhibition of CYP P450 3A, P-gp,…

VACS 2.0 Shows Improved Discrimination of Neurocognitive Impairment and Frailty in People With HIV

Background: The Veterans Aging Cohort Study (VACS) 1.0 Index is a generalizable risk index that combines and weights age, CD4 count and human immunodeficiency virus (HIV) type 1 RNA alone (Restricted Index), hemoglobin, FIB-4 Index, hepatitis C virus, and estimated glomerular filtration rate. The VACS 1.0 index more accurately discriminates mortality risk among persons with…

Further Evidence of Hypertrophy in Acute Infection Identified Using Machine Learning

Background: A recent study of structural brain volumes during acute HIV infection (AHI) revealed evidence of hypertrophy among individuals in Fiebig stages III-V compared to Fiebig I-II. The present study incorporated multiple neuroimaging modalities (structure and function), blood markers of inflammation and immune dysregulation, and psychosocial determinants of health using ensemble machine learning to more…

Associations Between a Polygenic Risk Score for Alzheimer’s Disease and Brain Integrity in HIV

Background: People living with HIV (PWH) continue to live to older ages making it difficult to differentiate between age-related neurocognitive disorders, such as Alzheimer disease (AD), and HIV-related neurocognitive impairment. Polygenic risk scores (PRS) allow for computing genetic risk for various diseases. This study leveraged a PRS calculated using the latest genome-wide association study for…

Protein Modifications by Lactate Associate With Lower Risks of Neurocognitive Impairment and Death

Background: In response to diverse infections, macrophages shift their main metabolism from oxidative phosphorylation to aerobic glycolysis, with lactate as the end-product. Ensuing increases in glycolytic flux promote the production of advanced glycation end products (AGEs), reactive glucose metabolites that alter protein function via non enzymatic, post-translational modifications (PTMs). These PTMs can modify cellular metabolism…

Improving Diagnosis of Central Nervous System Infections in High-HIV Prevalence African Settings

Background: Central nervous system infections (CNSI) account for approximately 30% of early mortality in ART programmes. The epidemiology of CNSI in high-HIV prevalence African settings is poorly understood making presumptive diagnosis and empiric treatment challenging. Patients with CNSI who do not receive a diagnosis have mortality rates of up to 40% at 10 weeks indicating…